Concepedia

Publication | Open Access

Weekly Somapacitan is Effective and Well Tolerated in Children With GH Deficiency: The Randomized Phase 3 REAL4 Trial

DOIFull Paper Access

55

Citations

25

References

2022

Year

Bradley S. Miller, Joanne Blair, Michael Højby Rasmussen, Aristides K Maniatis, Rasmus Juul Kildemoes, Jun Mori, Michel Polak, Rikke Beck Bang, Volker Böttcher, Stefano Stagi,
The Journal of Clinical Endocrinology & Metabolism

Abstract

Similar efficacy for somapacitan compared to daily GH was demonstrated over 52 weeks of treatment with comparable safety and mean IGF-I SDS levels in treatment-naïve children with GHD.

References

YearCitations

Page 1